Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000358233 | SCV000399275 | uncertain significance | Brittle cornea syndrome 1 | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001697666 | SCV000716253 | benign | not provided | 2018-08-15 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001697666 | SCV002397173 | benign | not provided | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV002278435 | SCV002565282 | likely benign | Ehlers-Danlos syndrome | 2022-02-17 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002402036 | SCV002705190 | benign | Cardiovascular phenotype | 2019-02-08 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |